Khan S, Barve KH, Kumar MS (2020) “Recent advancements in pathogenesis, diagnostics and treatment of Alzheimerʼs disease,” (in eng). Curr Neuropharmacol 18(11):1106–1125. https://doi.org/10.2174/1570159X18666200528142429
Article CAS PubMed PubMed Central Google Scholar
Neff RA et al (2021) Molecular subtyping of Alzheimerʼs disease using RNA sequencing data reveals novel mechanisms and targets. Sci Adv 7(2). https://doi.org/10.1126/sciadv.abb5398.
Sasaguri H et al (2022) “Recent advances in the modeling of Alzheimerʼs disease,” (in eng). Front Neurosci 16:807473. https://doi.org/10.3389/fnins.2022.807473
Article PubMed PubMed Central Google Scholar
McGowan E, Eriksen J, Hutton M (2006) “A decade of modeling Alzheimerʼs disease in transgenic mice,” (in eng). Trends Genet 22(5):281–289. https://doi.org/10.1016/j.tig.2006.03.007
Article CAS PubMed Google Scholar
Chin J (2011) “Selecting a mouse model of Alzheimerʼs disease,” (in eng). Methods Mol Biol 670:169–189. https://doi.org/10.1007/978-1-60761-744-0_13
Article CAS PubMed Google Scholar
Bilkei-Gorzo A (2014) “Genetic mouse models of brain ageing and Alzheimerʼs disease,” (in eng). Pharmacol Ther 142(2):244–257. https://doi.org/10.1016/j.pharmthera.2013.12.009
Article CAS PubMed Google Scholar
Gulyaeva NV, Bobkova NV, Kolosova NG, Samokhin AN, Stepanichev MY, Stefanova NA (2017) “Molecular and cellular mechanisms of sporadic Alzheimerʼs disease: studies on rodent models in vivo,” (in eng). Biochemistry (Mosc) 82(10):1088–1102. https://doi.org/10.1134/S0006297917100029
Article CAS PubMed Google Scholar
Ferreyra-Moyano H, Barragan E (1989) “The olfactory system and Alzheimerʼs disease,” (in eng). Int J Neurosci 49(3–4):157–197. https://doi.org/10.3109/00207458909084824
Article CAS PubMed Google Scholar
Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H (2008) “Olfaction in patients with mild cognitive impairment and Alzheimerʼs disease,” (in eng). Neurobiol Aging 29(5):693–706. https://doi.org/10.1016/j.neurobiolaging.2006.11.014
Attems J, Walker L, Jellinger KA (2014) “Olfactory bulb involvement in neurodegenerative diseases,” (in eng). Acta Neuropathol 127(4):459–475. https://doi.org/10.1007/s00401-014-1261-7
Article CAS PubMed Google Scholar
Marine N, Boriana A (2014) “Olfactory markers of depression and Alzheimerʼs disease,” (in eng). Neurosci Biobehav Rev 45:262–270. https://doi.org/10.1016/j.neubiorev.2014.06.016
Article CAS PubMed Google Scholar
Kovács T, Cairns NJ, Lantos PL (1999) “Beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimerʼs disease,” (in eng). Neuropathol Appl Neurobiol 25(6):481–491. https://doi.org/10.1046/j.1365-2990.1999.00208.x
Almeida RF et al (2017) “Olfactory bulbectomy in mice triggers transient and long-lasting behavioral impairments and biochemical hippocampal disturbances,” (in eng). Prog Neuropsychopharmacol Biol Psychiatry 76:1–11. https://doi.org/10.1016/j.pnpbp.2017.02.013
Article CAS PubMed Google Scholar
Avetisyan AV, Samokhin AN, Alexandrova IY, Zinovkin RA, Simonyan RA, Bobkova NV (2016) “Mitochondrial dysfunction in neocortex and hippocampus of olfactory bulbectomized mice, a model of Alzheimerʼs disease,” (in eng). Biochemistry (Mosc) 81(6):615–623. https://doi.org/10.1134/S0006297916060080
Article CAS PubMed Google Scholar
Bobkova NV et al (2004) “Morphofunctional changes in neurons in the temporal cortex of the brain in relation to spatial memory in bulbectomized mice after treatment with mineral ascorbates,” (in eng). Neurosci Behav Physiol 34(7):671–676. https://doi.org/10.1023/b:neab.0000036005.70153.3b
Article CAS PubMed Google Scholar
Han F, Shioda N, Moriguchi S, Qin ZH, Fukunaga K (2008) “The vanadium (IV) compound rescues septo-hippocampal cholinergic neurons from neurodegeneration in olfactory bulbectomized mice,” (in eng). Neuroscience 151(3):671–679. https://doi.org/10.1016/j.neuroscience.2007.11.011
Article CAS PubMed Google Scholar
Hozumi S et al (2003) “Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy,” (in eng). Behav Brain Res 138(1):9–15. https://doi.org/10.1016/s0166-4328(02)00183-3
Article CAS PubMed Google Scholar
Gurevich EV, Aleksandrova IA, Otmakhova NA, Katkov YA, Nesterova IV, Bobkova NV (1993) “Effects of bulbectomy and subsequent antidepressant treatment on brain 5-HT2 and 5-HT1A receptors in mice,” (in eng). Pharmacol Biochem Behav 45(1):65–70. https://doi.org/10.1016/0091-3057(93)90087-a
Article CAS PubMed Google Scholar
Aleksandrova IY et al (2004) “Increased level of beta-amyloid in the brain of bulbectomized mice,” (in eng). Biochemistry (Mosc) 69(2):176–180. https://doi.org/10.1023/b:biry.0000018948.04559.ab
Article CAS PubMed Google Scholar
Beck M, Bigl V, Rossner S (2003) “Guinea pigs as a nontransgenic model for APP processing in vitro and in vivo,” (in eng). Neurochem Res 28(3–4):637–644. https://doi.org/10.1023/a:1022850113083
Article CAS PubMed Google Scholar
Xie AJ et al (2016) “Cnga2 knockout mice display Alzheimerʼs-like behavior abnormities and pathological changes,” (in eng). Mol Neurobiol 53(7):4992–4999. https://doi.org/10.1007/s12035-015-9421-x
Article CAS PubMed Google Scholar
Battaglia F et al (2007) “Cortical plasticity in Alzheimerʼs disease in humans and rodents,” (in eng). Biol Psychiatry 62(12):1405–1412. https://doi.org/10.1016/j.biopsych.2007.02.027
Article CAS PubMed Google Scholar
Miller AH, Raison CL (2016) “The role of inflammation in depression: from evolutionary imperative to modern treatment target,” (in eng). Nat Rev Immunol 16(1):22–34. https://doi.org/10.1038/nri.2015.5
Article CAS PubMed PubMed Central Google Scholar
Hu J et al (2015) “Activation of glycogen synthase kinase-3 mediates the olfactory deficit-induced hippocampal impairments,” (in eng). Mol Neurobiol 52(3):1601–1617. https://doi.org/10.1007/s12035-014-8953-9
Article CAS PubMed Google Scholar
Takahashi K et al (2018) “Memantine ameliorates depressive-like behaviors by regulating hippocampal cell proliferation and neuroprotection in olfactory bulbectomized mice,” (in eng). Neuropharmacology 137:141–155. https://doi.org/10.1016/j.neuropharm.2018.04.013
Article CAS PubMed Google Scholar
Bobkova NV et al (2014) “Therapeutic effect of exogenous hsp70 in mouse models of Alzheimerʼs disease,” (in eng). J Alzheimers Dis 38(2):425–435. https://doi.org/10.3233/JAD-130779
Song C, Leonard BE (2005) “The olfactory bulbectomised rat as a model of depression,” (in eng). Neurosci Biobehav Rev 29(4–5):627–647. https://doi.org/10.1016/j.neubiorev.2005.03.010
Attems J, Lintner F, Jellinger KA (2005) “Olfactory involvement in aging and Alzheimerʼs disease: an autopsy study,” (in eng). J Alzheimers Dis 7(2):149–157. https://doi.org/10.3233/jad-2005-7208. (discussion 173-80)
Article CAS PubMed Google Scholar
Harkin A, Kelly JP, Leonard BE (2003) A review of the relevance and validity of olfactory bulbectomy as a model of depression. Clin Neurosci Res 3(4–5):253–262
留言 (0)